Unit 3: Economic Evaluation of Vaccines and Immunization Programs

Home > Unit 3: Economic Evaluation of Vaccines and Immunization Programs

Session 10: Introduction to Economic Evaluation

Learning objectives:

  1. Define basic concepts of economic evaluation

  2. Understand different methods and tools of economic evaluation

  3. Why perform an economic evaluation of a vaccine or immunization program

  4. What is an “ICER”?

  5. Translating value into resource allocation

Session 11: Scope of an Economic Evaluation

Learning Objectives:

  1. To define the scope of an economic evaluation

  2. To understand how to frame comparators for your audience based on a target population

  3. What are the alternatives to a vaccine program?

  4. To define the perspectives impacted by a vaccine program

  5. To understand how to frame the time horizon of a vaccine program

  6. To consider the impact of vaccines on different stakeholders at different time points

Session 12: Measuring and Valuing Health Outcomes

Learning Objectives:

  1. To describe measurement of health gains in terms of health state preference & natural units

  2. Defining patient preferences

  3. Instruments of effectiveness measurement

  4. Health utility measures

  5. Applying to economic evaluation

Session 13: Study Design Components of Economic Evaluation

Learning Objectives:

  1. To differentiate between uses of decision tree and Markov model

  2. To identify study designs that contribute to better cost, effectiveness and probability parameter estimates

  3. To understand the process of probability extraction from high-quality sources

Session 14: Introduction to Decision Tree Modelling

Building a decision tree model in Microsoft Excel, extracting Input Parameters, Calculating Weighted Outcomes, and Interpreting Results.

Session 15: Applying Economic Evaluation to COVID-19 Vaccine Introduction (Assignment)

Learning Objectives:

  1. Mapping the choices in COVID-19 deployment

  2. Applying ICERs to deployment strategies

  3. Considering equity and social justice in COVID-19 deployment